3

PRIMARY DOCUMENT

Company: RHYTHM PHARMACEUTICALS, INC.
Filed: October 4, 2017
Period of Report: October 4, 2017
Accession Number: 0001638599-17-001004

View Document ↗ View on SEC.gov ↗